Nisa Amoils

Nisa Amoils is a General Partner at Fifty Years based in New York City, New York, where she leads early-stage investments in biotechnology and frontier technologies. She holds a joint JD and MBA from the University of Pennsylvania Wharton School and Penn Law, and previously served as an Associate at Bessemer Venture Partners. Recognized on the 2023 Forbes 30 Under 30 list for venture capital, her investment portfolio includes prominent technology companies such as Tempus, PathAI, and Ginkgo Bioworks. In 2024, she directed a Series B funding round exceeding $100 million for an undisclosed biotechnology firm and recently presented on artificial intelligence in drug discovery at the 2025 JP Morgan Healthcare Conference. Amoils leverages her combined legal and financial expertise to identify and scale deep technology, healthcare, and life sciences enterprises.